Cannabis ETF Gains Momentum, Rising Over 8% As DEA Rescheduling Rumors Intensify (UPDATED)

Editor’s Note: This article has been updated to include a tweet from AdvisorShares Pure US Cannabis ETF (MSOS).

The cannabis industry seems to be sharing collective hopes Friday that this time the rumors of federal rescheduling are true, which has got weed stocks hitting the roof with speculation.

What Happened: Doug Kass, world-renowned hedge fund manager, posted
on X, formerly Twitter, Friday that the "DEA will approve a rescheduling of cannabis to Schedule III." 

“We have learned yesterday that the U.S. Drug Enforcement Administration will shortly approve a rescheduling of cannabis to Schedule III,” Kass said in part of his first tweet on the subject Friday. He advised selling a gap higher in cannabis stocks as a result of the rumored development.

Isn’t it time to get together and talk about all this exciting news? If you agree, DO NOT miss the upcoming Benzinga Cannabis Capital Conference in Florida where we will be discussing all things cannabis, including weed companies' valuations, earnings and investment opportunities. Join us at the new Hollywood venue on April 16 and 17, 2024.

Kass then posted a video on X of Sen. Cory Booker’s response Thursday when asked what he’s heard about the DEA’s rescheduling of cannabis.

“I have heard a lot about it,” Booker is seen saying at the U.S. Capital before a person asks “April 15?”
Booker then said: “I do not want to comment on that.”

The person exclaimed “Am I warm?” To this, Booker said “yes” and then joked about rescheduling possibly taking place on 4/20.

Meanwhile, AdvisorShares Pure US Cannabis ETF MSOS is still chugging up over 8% at $8.38 at the time of this update, mid-morning Friday and issued a stock alert:

New Cannabis Ventures, following this week’s cannabis earnings reports, some of which were up slightly, called the overall performance “another rough one for MSOs,” referring to multi-state operators.

“Another Tier 1 name reported, the fifth of five companies, and the four Tier 2 companies reported as well. Through Thursday's close, the New Cannabis Ventures American Cannabis Operator Index has declined 6.9% and was now down 16.4% so far in March,” wrote New Cannabis Ventures on Friday. “It is up 6.4% year-to-date. While the performance has slipped recently, it's still better than for other sectors.

The NCV Global Cannabis Stock Index was down 0.2% year-to-date through 3/14.

The two-day Benzinga Cannabis Capital Conference at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn, and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world. Get your tickets now on bzcannabis.com – Prices will increase very soon!

Illustration made using Pixabay photo.